Bladder Cancer—Patient Version
Overview
The most common type of bladder cancer is transitional cell carcinoma, also called urothelial carcinoma. Smoking is a major risk factor for bladder cancer. Bladder cancer is often diagnosed at an early stage. Explore the links on this page to learn more about bladder cancer treatment, screening, statistics, research, and clinical trials.
Treatment
PDQ Treatment Information for Patients
Causes & Prevention
NCI does not have PDQ evidence-based information about prevention of bladder cancer.
More information
Screening
PDQ Screening Information for Patients
Statistics
Bladder Cancer Statistics | Did You Know?
Coping with Cancer
The information in this section is meant to help you cope with the many issues and concerns that occur when you have cancer.
Feelings and Cancer Adjusting to Cancer Support for Caregivers Survivorship Advanced Cancer Managing Cancer CareResearch
Enfortumab Vedotin Approved for Recurrent Bladder Cancer
Targeted Drug Erdafitinib Benefits Some Patients with Advanced Bladder Cancer
FDA Alters Approved Use of Two Checkpoint Inhibitors for Bladder Cancer
New Treatment Approach Could Help Prevent Recurrences of Some Bladder Cancers
View more research